Works matching IS 02724391 AND DT 1995 AND VI 34 AND IP 3

Results: 9

General pharmacology of SDZ WAG 994, a potent selective and orally active adenosine A1 receptor agonist.

Published in:

Drug Development Research, 1995, v. 34, n. 3, p. 276, doi. 10.1002/ddr.430340305

By:

Wagner, Heribert;
Milavec-Krizman, Maria;
Gadient, Fulvio;
Menninger, Klaus;
Schoeffter, Philippe;
Tapparelli, Carlo;
Pfannkuche, Hans-Jürgen;
Fozard, John R.

Publication type:

Article

Masthead.

Published in:: Drug Development Research, 1995, v. 34, n. 3, p. fmi, doi. 10.1002/ddr.430340301
Publication type:: Article

Olanzapine moderately increases conflict responding but does not produce a benzodiazepine-like cue in rat.

Published in:

Drug Development Research, 1995, v. 34, n. 3, p. 317, doi. 10.1002/ddr.430340309

By:

Nanry, Kevin P.;
Pollard, Gerald T.;
Howard, James L.

Publication type:

Article

Pharmacology of the human metabolites of dolasetron, an antiemetic 5-HT3 receptor antagonist.

Published in:

Drug Development Research, 1995, v. 34, n. 3, p. 289, doi. 10.1002/ddr.430340306

By:

Bigaud, Marc;
Elands, Jack;
Kastner, Philip R.;
Bohnke, Rick A.;
Emmert, Lee W.;
Galvan, Martin

Publication type:

Article

Pharmacological antagonism of α-adrenergic agonist induced increases in canine intraurethral pressure in vivo.

Published in:

Drug Development Research, 1995, v. 34, n. 3, p. 267, doi. 10.1002/ddr.430340304

By:

Brune, Michael E.;
Buckner, Steven A.;
Polakowski, James;
Kerwin, James F.;
Hancock, Arthur A.

Publication type:

Article

D2 and 5-HT2 modulation of psychostimulant-induced facilitation of brain stimulation reward.

Published in:

Drug Development Research, 1995, v. 34, n. 3, p. 297, doi. 10.1002/ddr.430340307

By:

Tsibulsky, Vladimir;
Dashevsky, Boris;
Frank, Robert A.

Publication type:

Article

Diagnosing the decline of major pharmaceutical research laboratories: A prescription for drug companies.

Published in:

Drug Development Research, 1995, v. 34, n. 3, p. 243, doi. 10.1002/ddr.430340302

By:

Weisbach, Jerry A.;
Moos, Walter H.

Publication type:

Article

Biological activity of WIN 63759, an orally bioavailable inhibitor of human neutrophil elastase.

Published in:

Drug Development Research, 1995, v. 34, n. 3, p. 306, doi. 10.1002/ddr.430340308

By:

Silver, Paul J.;
Gordan, Robert J.;
Pagani, Edward D.;
Johnson, Judith A.;
Maycock, Alan L.;
Dunlap, Richard P.;
Ferguson, Edward W.;
Franke, Catherine A.;
Drozd, Marion L.;
Robinson, David T.;
Mark Eickhoff, W.;
Baizman, Eugene R.;
Subramanyam, Chakrapani;
Desai, Ranjit C.;
Hlasta, Dennis J.;
Newton, John F.

Publication type:

Article

Expression and characerization of human kainate receptor subunits in Escherichia coli and mammalian cells.

Published in:

Drug Development Research, 1995, v. 34, n. 3, p. 260, doi. 10.1002/ddr.430340303

By:

Foldes, Robert L.;
Fantaske, Robert P.;
Korczak, Bozena;
Hoo, Ken H.;
Nutt, Stephen L.;
Kamboj, Rajender K.

Publication type:

Article

Works matching IS 02724391 AND DT 1995 AND VI 34 AND IP 3

General pharmacology of SDZ WAG 994, a potent selective and orally active adenosine A<sub>1</sub> receptor agonist.

Masthead.

Olanzapine moderately increases conflict responding but does not produce a benzodiazepine-like cue in rat.

Pharmacology of the human metabolites of dolasetron, an antiemetic 5-HT<sub>3</sub> receptor antagonist.

Pharmacological antagonism of α-adrenergic agonist induced increases in canine intraurethral pressure in vivo.

D<sub>2</sub> and 5-HT<sub>2</sub> modulation of psychostimulant-induced facilitation of brain stimulation reward.

Diagnosing the decline of major pharmaceutical research laboratories: A prescription for drug companies.

Biological activity of WIN 63759, an orally bioavailable inhibitor of human neutrophil elastase.

Expression and characerization of human kainate receptor subunits in Escherichia coli and mammalian cells.